Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Non-Small-Cell Lung 44Colorectal Neoplasms 22Breast Neoplasms 22Stomach Neoplasms 21Neoplasms 18Esophageal Squamous Cell Carcinoma 12Neoplasm Metastasis 11Nasopharyngeal Carcinoma 11Lung Neoplasms 11Rectal Neoplasms 9Colonic Neoplasms 8Pancreatic Neoplasms 7Uterine Cervical Neoplasms 6Esophageal Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Ovarian Neoplasms 5Osteosarcoma 5Brain Neoplasms 5Small Cell Lung Carcinoma 4Recurrence 4Glioblastoma 4Gastrointestinal Neoplasms 4Precision Cell Immunotherapy 3Melanoma 3Lymphoma, Non-Hodgkin 3Lymphoma 3Head and Neck Neoplasms 3Gastrointestinal Diseases 3Digestive System Neoplasms 3Carcinoma, Ovarian Epithelial 3

Interventions

surufatinib 2regorafenib 2Oxaliplatin 2Irinotecan 2Fluorouracil 2Drug Therapy 2Bevacizumab 2raltitrexed 1nimotuzumab 1endostar protein 1aflibercept 1Folfox protocol 1Cetuximab 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Advanced Colorectal Cancer × Drug Therapy × Clear all
NCT05928312 2023-07-20

Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer

Zhejiang Cancer Hospital

Phase NA Unknown
72 enrolled
Gastrointestinal

Advanced Colorectal Cancer

NCT00972465 2009-09-07

Study of Nimotuzumab to Treat Colorectal Cancer

Peking University

Phase 2 Unknown
48 enrolled
Gastrointestinal

Advanced Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡